Explore
Intelligence
Safety Audit ยท 19,429 ft
Personalized altitude sickness risk assessment for Baljuri Peak Expedition. 60 seconds. No health data stored.
Baljuri Peak Expedition at a Glance
At 19,429ft, altitude sickness is a genuine high-altitude hazard on Baljuri Peak Expedition. The calculator above personalises your risk based on your medical history, prior altitude experience, and this route's specific ascent profile.
Frequently Asked Questions
Supplemental oxygen is generally not required for this 5,922m peak if properly acclimatized, but professional teams carry emergency cylinders.
The primary risks on Baljuri Peak Expedition are: Crevasse falls on glacier approach, Acute Mountain Sickness (AMS) / HACE / HAPE, Exposed ridge slips, Extreme sub-zero temperatures and high winds. Your operator should brief you on each of these before departure.
Diamox (Acetazolamide) is worth discussing with your doctor if you plan to attempt Baljuri Peak Expedition (19,429ft). It is not routinely required for healthy trekkers but is recommended if you have had AMS symptoms on a previous high-altitude trip. Never start Diamox without medical advice โ it has side effects including tingling fingers and increased urination.
At 5,922m, a resting SpO2 below 80% is a medical emergency and requires immediate descent. Between 80โ85% โ monitor closely and do not ascend further. Most acclimatized trekkers maintain 85โ92% at this altitude. Carry a pulse oximeter and check readings morning and night.
Strictly prohibited. All high-altitude peaks require IMF permits and certified mountain guide supervision.
Compare verified operators who carry full oxygen support and pulse-oximetry checks.
Compare operators